Neogen (NEOG) Cash from Operations Growth (3y) (2013 - 2026)
Neogen (NEOG) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 0.50% |
| 10 | Neogen | 2.05 Bn | 1.89 Bn | 99.00 Mn | 49.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 49.33% |
| Nov 30, 2025 | 44.84% |
| Aug 31, 2025 | 40.40% |
| May 31, 2025 | -6.92% |
| Feb 28, 2025 | 43.46% |
| Nov 30, 2024 | 31.14% |
| Aug 31, 2024 | -40.47% |
| May 31, 2024 | 6.78% |
| Feb 29, 2024 | -66.37% |
| Nov 30, 2023 | -11.13% |
| Aug 31, 2023 | -2.90% |
| May 31, 2023 | 52.54% |
| Feb 28, 2023 | -42.00% |
| Nov 30, 2022 | -46.09% |
| Aug 31, 2022 | -37.44% |
| May 31, 2022 | -0.78% |
| Feb 28, 2022 | -14.05% |
| Nov 30, 2021 | 2.65% |
| Aug 31, 2021 | 13.01% |
| May 31, 2021 | -0.87% |